Ⓒ Copyright 2022 ABC Global Alliance
VAT/NIPC 515 732 230
Sign up to the newsletter
Oops! Something went wrong while submitting the form.
A diagnosis of brain metastases or leptomeningeal disease (LMD) from breast cancer is devastating for patients, and presents treatment challenges to the clinical team.
Research and clinical trials are continuously improving our understanding of brain metastases and LMD, also known as central nervous system (CNS) metastases. Both patients and healthcare providers need accurate, up-to-date information about diagnosis and treatment.
Our hub connects you to resources that have been reviewed by medical experts and patient advocates from the CNS Working Group, a global initiative of the Breast International Group (BIG) and the National Clinical Trial Network (NCTN). Many resources can be viewed in your own language using our ReciteMe tool – see how to use it.
On Friday, November 7, you will be able to submit your own resources to the ABC Global Alliance.
We invite you to prepare your materials and join us in sharing and collaborating for meaningful global impact.
